End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 USD | 0.00% | -1.84% | +16.29% |
30/04 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
30/04 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Chart calendar Alvotech
Upcoming events on Alvotech
Past events on Alvotech
14/05/2024 | BofA Securities Health Care Conference |
03/04/2024 05:45 pm | Business Update Call |
22/03/2024 07:30 pm | Capital Markets Day |
21/03/2024 05:30 pm | Q4 2023 Earnings Call |
21/03/2024 01:45 am | Q4 2023 Earnings Release |
29/11/2023 06:30 pm | Q3 2023 Earnings Call |
29/11/2023 02:45 am | Q3 2023 Earnings Release |
15/11/2023 06:30 pm | Jefferies London Healthcare Conference |
19/09/2023 | Northland Capital Markets Institutional Investor Conference |
31/08/2023 05:30 pm | Q2 2023 Earnings Call |
31/08/2023 01:45 am | Q2 2023 Earnings Release |
08/06/2023 02:00 am | Jefferies Global Healthcare Conference |
06/06/2023 12:30 pm | Annual General Meeting |
22/05/2023 07:45 pm | Morgan Stanley Sustainable Finance Summit |
19/05/2023 05:30 pm | Q1 2023 Earnings Call |
19/05/2023 02:30 pm | Q1 2023 Earnings Release |
02/03/2023 06:30 pm | Q4 2022 Earnings Call |
02/03/2023 03:00 am | Q4 2022 Earnings Release |
17/11/2022 03:55 pm | Jefferies London Healthcare Conference |
16/11/2022 06:30 pm | Q3 2022 Earnings Call |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 36,8 | 83,0 104 -20.49% | 93,4 133 -29.99% | 353 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -326 -212 -53.62% | -331 -271 -21.8% | 60,7 |
EBIT Million USD | Released Forecast Spread | 0,00 | -346 -260 -33.47% | -355 -254 -39.67% | 20,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -552 -375 -47.16% | -651 -346 -88.16% | -184 |
Net income Million USD | Released Forecast Spread | 0,00 | -514 -313 -64.08% | -552 -271 -103.47% | -149 |
EPS USD | Released Forecast Spread | -12,3 | -2,60 -1,55 -67.68% | -2,43 -1,09 -123% | -0,60 |
Announcement Date | 10/05/22 | 01/03/23 | 20/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q2 |
---|---|---|
Net income Million USD | Released Forecast Spread | 189 |
EPS USD | Released Forecast Spread | 0,85 |
Announcement Date | 30/08/23 |
21/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
22/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
22/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
01/07/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Alvotech
Today 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
15/05/2024 01:35 am | NUVATION BIO INC.: Q1 2024 Earnings Release |
14/05/2024 05:00 pm | ABSCI CORPORATION: Q1 2024 Earnings Release |
14/05/2024 11:20 am | BELITE BIO, INC: Q1 2024 Earnings Release |
14/05/2024 | POLARIS GROUP: Q1 2024 Earnings Release |
14/05/2024 02:00 am | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
13/05/2024 04:30 pm | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
13/05/2024 04:30 am | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALVO Stock
- Calendar Alvotech